USE OF DNA PROBES FOR THE DETECTION OF LYME DISEASE

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$49,110.00
Award Year:
1990
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Agency Tracking Number:
13606
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Biotech Research Laboratories
1600 E Gude Dr, Rockville, MD, 20850
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Mark M Manak
(301) 251-0800
Business Contact:
() -
Research Institution:
n/a
Abstract
THE TREATMENT OF LYME DISEASE COULD BE GREATLY ENHANCED IF IT WERE POSSIBLE TO DETECT THE LYME DISEASE SPIROCHETE DIRECTLY IN BLOOD WITH A HIGHLY SENSITIVE TEST. IT IS PLANNED TO DEVELOP A TEST WHERE A REGION OF THE BORRELIA BURGDORFERI OSPA GENE IS AMPLIFIED USING THE POLYMERASE CHAIN REACTION (PCR) TO OBTAIN THE NECESSARY SENSITIVITY. THE AMPLIFIED PRODUCT WILL BE DETECTED INITIALLY BY SOUTHERNBLOTTING AND EVENTUALLY BY SANDWICH HYBRIDIZATION IN MICROTITER WELLS USING A NONRADIOACTIVE DNA PROBE. IN PHASE I, THE REAGENTS NECESSARY FOR THE PCR AMPLIFICATION OF B. BURGDORFERI DNA WILL BE DEVELOPED, AND, IF POSSIBLE, THE FEASIBILITY OF DETECTING THE SPIROCHETE USING THE PCR AND SOUTHERN BLOTTING WILL BE TESTED. A DIRECT AND SENSITIVE TEST OF THIS TYPE FOR LYME DISEASE SHOULD PERMIT EARLIER DETECTION, BETTER DIAGNOSTIC CONFIRMATION, AND EFFECTIVE MONITORING OF ANTIBIOTIC THERAPY.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government